Status:

RECRUITING

Effectiveness of Multimodal Physical Therapy in Migraine

Lead Sponsor:

Neuromed IRCCS

Conditions:

Migraine

Musculoskeletal Neck Pain

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

INTRODUCTION: It is very common that migraine patients could refer neck pain during or after the pain phase of migraine, suggesting that migraine pathophysiological mechanisms could be effective in ac...

Detailed Description

Study design This is a prospective, parallel group, randomized clinical trial evaluating multimodal care plus usual care vs. usual care alone in episodic and chronic migraine with concomitant muscolos...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • patients aged 18-65 years;
  • patients with episodic migraine with and without aura (experiencing 6-14 days/month with migraine);
  • patients with chronic migraine;
  • patients who achieved \>30% \<50% reduction from their individual baseline in the number of monthly migraine days on therapy with standard stable pharmacological treatments during the past 3 months;
  • concomitant cervical dysfunctions.
  • Exclusion criteria
  • self-report of neck injury/trauma;
  • acute radiculopathy;
  • history of carotid or vertebral artery dissection;
  • stroke;
  • cervical/cranial nerve block in the past three months;
  • pregnancy;
  • history of infection;
  • migraine attack during the assessment;
  • diagnosis of other concomitant headaches (such as cervicogenic headache, tension-type headache, cluster headache, medication overuse headache);
  • having received physical treatment in the past three months or botulinum toxin in the past six months;
  • any unstable medical o psychiatric condition.
  • history of any other rheumatic or chronic diseases such as fibromyalgia;
  • neuralgias, or self-report of vestibular disease.

Exclusion

    Key Trial Info

    Start Date :

    February 24 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2025

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT05226559

    Start Date

    February 24 2022

    End Date

    May 1 2025

    Last Update

    February 28 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    IRCCS Neuromed

    Pozzilli, Isernia, Italy, 86077